ResMed Inc. (ASX: RMD) Share Price and News
Price
Movement
(20 mins delayed)
52 Week Range
-
1 Year Return
ResMed Inc. Chart and Price Data
Fundamentals Data provided by Morningstar.
Share Price
Day Change
52 Week Range
-
Yesterday's Close
Today's Open
Days Range
-
Volume
Avg. Volume (1 month)
Turnover
as at 24 Feb 3:44pm
ResMed Inc. (ASX: RMD)
Latest News
Share Market News
5 things to watch on the ASX on Friday
⏸️ Growth Investing
There 3 under-the-radar healthcare shares could make you rich
Share Market News
Earnings season week one preview
Share Market News
Top forecaster warns Aussie to drop below US70 cents in a Trump Trade War
Healthcare Shares
Should you buy these 3 ASX healthcare giants?
Growth Shares
3 blue-chip healthcare companies to add to your portfolio
Share Market News
Google parent Alphabet and ResMed Inc. agree to form new digital health company
Share Market News
How do I interpret a company's price-to-earnings (PE) ratio?
⏸️ Investing
Hospital stocks like Ramsay Health Care Limited (ASX:RHC) face a new risk in FY19
⏸️ Investing
5 things to watch on the ASX on Monday
Healthcare Shares
Top broker slaps buy ratings on CSL Limited (ASX:CSL) and ResMed Inc (ASX:RMD) shares
⏸️ Investing
ALL ORDINARIES (ASX:XAO) gains 9% in FY18
Frequently Asked Questions
-
Yes. As well as being listed on the ASX since November 1999, ResMed trades on the New York Stock Exchange under the ticker code NYSE: RMD.
-
Yes, historically ResMed pays unfranked quarterly dividends each year. It does not offer a dividend reinvestment plan.
RMD ASX Announcements
An announcement is considered as "Price Sensitive" if it is thought that it may have an impact on the price of the security.
| Date | Announcement | Price Sensitive? | Time | No. of Pages | File Size |
|---|---|---|---|---|---|
| YesNo |
About ResMed Inc.
ResMed Inc (ASX: RMD) is a global leader in sleep technology. It develops, manufactures, and distributes medical devices – such as flow generators, CPAP masks, and accessories – and cloud-based software applications that diagnose, treat, and manage a range of respiratory disorders including sleep apnea, chronic obstructive pulmonary disease (COPD), and neuromuscular disease.
It also provides software platforms to support professionals and caregivers to help patients in an out-of-hospital setting. The company operates in more than 140 countries, with manufacturing facilities in Australia, Singapore, France, and the United States. ResMed was established in Australia in 1989 but is now based in San Diego in the United States.
